Immediate exposure to TNF-alpha activate dendritic cells derived from non-purified cord blood mononuclear cells

Iran J Immunol. 2009 Sep;6(3):107-18.

Abstract

Background: Tumor necrosis factor alpha (TNF-alpha) is a primary mediator of immune regulation and might be required in the early stages of DC development from CD34+ cells. However, details of optimal timing of exposure to TNF-alpha in DC development process in monocytes or non-purified hematopoitic cells are still lacking and clear benefits of this approach to the development of DCs remain to be validated.

Objective: To evaluate the effect of early and late exposure to TNF-alpha on DC development from non-purified cord blood mononuclear cells.

Methods: To define the effects of early exposure to TNF-alpha on cord blood mononuclear cells, we cultured UCB-MNC in the presence of SCF, Flt3L, GM-CSF and IL-4 for 14 days and matured them for an extra 4 days. TNF-alpha was added on day 0, 7 and 14 in TNF-alpha + group, and only on day 14 in TNF-alpha - group where it was used only as a maturation factor.

Results: Immediate exposure to TNF-alpha was shown to: (1) enhance the survival of cells in the first week of culture; (2) produce mature DCs with higher maturation markers (CD80, CD83, CD86 and HLA-DR); and (3) increase secretion of IL-12 by mature DCs. In contrast, delayed exposure to TNF-alpha stimulate mature DCs with less purity producing a high level of IL-10 and a low level of IL-12.

Conclusion: We developed a simple, easy and cost effective method to generate DCs from non-fractionating mononuclear cells in this study. Also we confirm the presence of a large number of functional DCs under inflammatory conditions, where local concentrations of TNF-alpha were high.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Antigens, CD / metabolism
  • Dendritic Cells / cytology
  • Dendritic Cells / immunology*
  • Fetal Blood / cytology
  • Fetal Blood / drug effects
  • Fetal Blood / immunology
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Humans
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / immunology
  • Interleukin-12 / biosynthesis
  • Interleukin-12 / immunology
  • Interleukin-4 / pharmacology
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / immunology
  • Membrane Proteins / pharmacology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Adjuvants, Immunologic
  • Antigens, CD
  • IL10 protein, human
  • IL4 protein, human
  • Membrane Proteins
  • Tumor Necrosis Factor-alpha
  • flt3 ligand protein
  • Interleukin-10
  • Interleukin-12
  • Interleukin-4
  • Granulocyte-Macrophage Colony-Stimulating Factor